Release Date: 30/03/10 15:26 Summary: MUE - Interim Report 2010 Price Sensitive: No Download Document 870.94KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%